New chemo schedule shows promise for tough pancreatic cancer
Disease control
Recruiting now
This study tests whether changing the timing of two chemotherapy drugs (gemcitabine and nab-paclitaxel) can better shrink tumors in people with pancreatic cancer that has spread. About 67 adults with metastatic pancreatic cancer will receive the drugs on a new schedule. The goal …
Phase: PHASE2 • Sponsor: Anne Noonan • Aim: Disease control
Last updated May 04, 2026 01:51 UTC